Author profile: Argüelles Arias, Federico
Institutional data
| Name | Argüelles Arias, Federico |
| Department | Medicina |
| Knowledge area | Medicina |
| Professional category | Profesor Contratado Doctor (Plaza Vinc.) |
| Request | |
 |
|
Statistics
-
No. publications
29
-
No. visits
2584
-
No. downloads
5848
| Publications |
|---|
PhD Thesis
 Evaluación de la variabilidad interobservador de las escalas endoscópicas de actividad en pacientes con enfermedad de Crohn y su correlación con índices clínicos y biomarcadores
(2023-05-18)
Introducción: La evaluación de la actividad endoscópica en pacientes con enfermedad de Crohn (EC) es de gran relevancia ... |
PhD Thesis
Pseudopólipos inflamatorios en pacientes con enfermedad inflamatoria intestinal: correlación entre hallazgos macroscópicos y microscópicos, clasificación histológica e implicaciones clínicas
(2023-05-18)
Los pseudopólipos inflamatorios (PPII) son lesiones no neoplásicas que aparecen como consecuencia de repetidos ciclos de ... |
Article
 Clinical Utility of Urinary Gluten Immunogenic Peptides in the Follow-up of Patients with Coeliac Disease
(Wiley-Blackwell, 2023-01-01)
Background: Gluten-free diet (GFD) is the only treatment for patients with coeliac disease (CD). and its compliance should ... |
Article
Effectiveness and safety of ustekinumab in bio-naive Crohn's disease patients: a multicentre observational retrospective study
(SAGE Publishing, 2023-01-01)
Background: Clinical trials have demonstrated the efficacy and safety of ustekinumab in Crohn’s disease (CD). However, ... |
Article
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
(MDPI, 2022-12-19)
Scant information is available concerning the characteristics that may favour the acquisition of COVID-19 in patients with ... |
Article
Long-term real-world effectiveness and safety of ustekinumab in Crohn's disease patients: the SUSTAIN study.
(Oxford University Press, 2022-01-01)
Background: Large real-world-evidence studies are required to confirm the durability of response, effectiveness, and safety ... |
Article
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
(Frontiers Media S.A., 2022-01-01)
Background: Previous studies comparing immigrant ethnic groups and native patients with IBD have yielded clinical and ... |
Article
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
(MDPI, 2022-01-01)
We aim to describe the incidence and source of contagion of COVID-19 in patients with IBD, as well as the risk factors for ... |
Article
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
(MDPI, 2022-01-01)
Ustekinumab has shown efficacy in Crohn’s Disease (CD) patients. To identify patient profiles of those who benefit the ... |
Article
Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: results from the VERNE study
(Elsevier, 2022-01-01)
Background Anti-TNFα represent one of the main treatment approaches for the management of inflammatory bowel diseases ... |
Article
Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain
(Sage Publishing, 2022-01-01)
Background: Iron deficiency anemia (IDA) is a common complication of inflammatory bowel disease (IBD) and can result in ... |
Article
Native Chilean Berries Preservation and In Vitro Studies of a Polyphenol Highly Antioxidant Extract from Maqui as a Potential Agent against Inflammatory Diseases
(MDPI, 2021-05-01)
The best conservation method for native Chilean berries has been investigated in combination with an implemented large-scale ... |
PhD Thesis
Monitorización de niveles de Infliximab y anticuerpos Anti-Infliximab en pacientes con enfermedad inflamatoria intestinal en práctica clínica
(2021-03-24)
Introducción Infliximab (IFX) es un fármaco anti-TNF que consigue una buena tasa de respuesta y remisión en muchos pacientes ... |
Article
Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome
(SAGE Publishing, 2021-01-01)
Background: Irritable bowel syndrome with diarrhoea (IBS-D) is a frequent problem associated with a significant socioeconomic ... |
Article
Comparison of the Mayo Endoscopy Score and the Ulcerative Colitis Endoscopy Index of Severity and the Ulcerative Colitis Colonoscopy Index of Severity
(Thieme, 2021-01-01)
Background and study aims: Endoscopy plays an essential role in managing patients with ulcerative colitis (UC), as it ... |
Article
Perspectiva de los pacientes con enfermedad inflamatoria intestinal durante la pandemia COVID-19: resultados Encuesta ACCU
(Arán Ediciones, S.L., 2021-01-01)
Introducción y objetivos: la pandemia por el SARS-CoV-2 ha obligado a un cambio sustancial en la atención a los pacien- tes ... |
PhD Thesis
Evaluación de la variabilidad interobservador de los scores endoscópicos que valoran la actividad de la enfermedad en pacientes con colitis ulcerosa
(2020-05-27)
Objetivos: el objetivo principal del estudio fue evaluar la variabilidad interobservador para el Índice de Mayo Endoscópico ... |
Article
Small Bowel Enteroscopy-A Joint Clinical Guideline from the Spanish and Portuguese Small Bowel Study Groups
(Karger Publishers, 2020-04-21)
The present evidence-based guidelines are focused on the use of device-assisted enteroscopy in the management of small-bowel ... |
Article
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: The VERNE study
(BMJ Publishing Group, 2020-01-01)
Objective To evaluate the impact of comorbidities and extraintestinal manifestations of inflammatory bowel disease on the ... |
Article
Polyphenolic Maqui Extract as a Potential Nutraceutical to Treat TNBS-Induced Crohn' s Disease by the Regulation of Antioxidant and Anti-Inflammatory Pathways
(MDPI, 2020-01-01)
Nutraceuticals include a wide variety of bioactive compounds, such as polyphenols, which have been highlighted for their ... |
Article
Polymeric nanoparticles for drug delivery: Recent developments and future prospects
(Multidisciplinary Digital Publishing Institute (MDPI), 2020-01-01)
The complexity of some diseases—as well as the inherent toxicity of certain drugs—has led to an increasing interest in the ... |
Article
Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data
(Original Research, 2019-01-01)
Background: Several studies have reported positive efficacy outcomes for patients with inflammatory bowel disease treated ... |
PhD Thesis
Valoración de la eficacia de Infliximab biosimilar (CT-P13, remsima®) frente al Infliiximab original (Remicade®) en pacientes con enfermedad inflamatoria intestinal.
(2018-05-16)
Introducción: las terapias biológicas, particularmente agentes anti-TNF alfa, han revolucionado el enfoque terapéutico de ... |
Article
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results
(Lippincott Williams & Wilkins, 2017-01-01)
Background: Biological agents, such as infliximab, have transformed the outcomes of patients with immune-mediated inflammatory ... |
PhD Thesis
Estudio comparativo, prospectivo y randomizado de tres preparaciones para el estudio del colon mediante cápsula endoscópica de colón
(2016-12-05)
Introducción y objetivos. El cáncer colorrectal (CCR) representa en conjunto el 10% de todos los tumores a nivel mundial. ... |
| Article |
| Article |
| Article |
Article
Accidental intrarectal administration of alcohol enema induces proctocolitis and fecal incontinence
(Georg Thieme, 2001-07-18)
|